DigestRedComo funciona
Red
/
Empresas
Me
No verificado

Merck

Sobre qué escribimos

BiotecnologíaFarmacéuticaIndustriaMedicina - VariosSalud

42 Comunicados de prensa

Ver todos los comunicados de prensa
16/07/2026
Anuncios breves
Merck Opens BioReliance® Testing Facility in Darmstadt, Germany to Support Drug Product Release in Europe
Fuente
Merck
Editor
GLOBENEWSWIRE
1.00
0
14/07/2026
Ciencia
Material médico sanitario
Biotecnología
Medicina - Varios
Farmacéutica
Salud
Oncología
Industria
European Commission Approves Erbitux® (cetuximab) in Combination with Encorafenib and FOLFOX for First-Line Treatment of Metastatic Colorectal Cancer with BRAF V600E Mutation
Fuente
Merck
Editor
Business Wire
1.00
0
08/07/2026
Sanidad
Ciencia
Farmacéutica
Biotecnología
Medicina - Varios
Higiene alimentaria
Salud
Industria
Merck Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients With Active Skin Manifestations
Fuente
Merck
Editor
Business Wire
1.00
0
23/06/2026
Mercado laboral
Ciencia
Cardiología
Biotecnología
Farmacéutica
Salud
Merck Collaborates with Versant Ventures to Launch Saturnus Bio to Advance Treatments for Rare Genetic Cardiomyopathies
Fuente
Merck
Editor
Business Wire
1.00
0
08/06/2026
Anuncios breves
Merck Appoints New Heads of Discovery Solutions and Strategy & Business Development for Life Science Business Sector
Fuente
Merck
Editor
GLOBENEWSWIRE
1.00
0
21/05/2026
Oncología
Salud
Medicina - Varios
Ciencia
Farmacéutica
Industria
Merck Announces First Patient Dosed in Phase 3 Study for Investigational Antibody-Drug Conjugate in Colorectal Cancer
Fuente
Merck
Editor
Business Wire
1.00
0
07/05/2026
Anuncios breves
Merck Becomes Sole Testing Provider for Genetix Biotherapeutics’ FDA-Approved Gene Therapies
Fuente
Merck
Editor
GLOBENEWSWIRE
1.00
0
30/04/2026
Merck Announces First Dose in Phase 3 Study with Enpatoran for Lupus Patients with Active Skin Manifestations
Fuente
Merck
Editor
Business Wire
1.00
0
21/04/2026
Anuncios breves
Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography
Fuente
Merck
Editor
GLOBENEWSWIRE
1.00
0
01/04/2026
Anuncios breves
Merck Completes Acquisition of JSR Life Sciences’ Chromatography Business, Expanding Protein A Capabilities and Downstream Portfolio
Fuente
Merck
Editor
GLOBENEWSWIRE
1.00
0

Detalles de contacto

Redes sociales

Seguidores
0
Compatibilidad
0